Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07130058 · ClinicalTrials.gov registry record · NA

Radicle GI HealthTM RCA: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

A NA study of GI Health, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07130058: Completed NA study of GI Health, sponsored by Radicle Science.

NCT07130058 is a NA study of GI Health that has completed, run by Radicle Science. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07130058, a NA study of GI Health, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes

Primary Outcome

Difference between rates of change over time in gas and bloating score as assessed by PROMIS Gas and Bloating 13A (scale 3-60; where the higher scores correspond to worse gas and bloating)

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT GI Product Form - Control
  • DIETARY_SUPPLEMENT GI Health Product Form - Active

Study Locations (1)

California

  • Radicle Science, Inc - Del Mar

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-08-14
Est. Completion 2025-11-10
Phase NA
Radicle Science

55 total trials

What the finished NCT07130058 record still lists

NCT07130058 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 1 condition, with GI Health appearing as the primary indexed condition, and to 2 interventions - of which GI Product Form - Control is the first listed.

NCT07130058 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07130058 about?

NCT07130058 is a clinical study titled "Radicle GI HealthTM RCA: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes

What is the current status of trial NCT07130058?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2025-08-14. Estimated completion is 2025-11-10.

What conditions does trial NCT07130058 study?

This clinical trial studies the following conditions: GI Health.

What interventions are being tested in trial NCT07130058?

The interventions under investigation include: GI Product Form - Control (DIETARY_SUPPLEMENT), GI Health Product Form - Active (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07130058?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07130058 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for GI Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07130058's enrollment target sits among peer trials

500 193rd of 2000 higher than 1,788 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07130058, the US trial registry maintained by the National Library of Medicine. NCT07130058 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.